MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02970nam a22004217a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240807s20242024 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
2213-1779 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
S2213-1779(24)00338-X [pii] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
38878007 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF. |
| 251 ## - Source |
|---|
| Source |
JACC Heart Failure. 2024 Jun 01 |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
JACC Heart Fail. 2024 Jun 01 |
| 253 ## - Journal Name |
|---|
| Journal name |
JACC. Heart failure |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2024 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Manufacturer |
FY2024 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Publication date |
2024 Jun 01 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
aheadofprint |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Medline status |
Publisher |
| 266 ## - Date added to catalog |
|---|
| Date added to catalog |
2024-08-07 |
| 266 ## - Date added to catalog |
|---|
| Date Medline record created |
2024/06/15 10:32 |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
BACKGROUND: The efficacy of sotagliflozin in patients with diabetes and recent worsening of heart failure was shown in the SOLOIST-WHF trial. However, the cost-effectiveness of sotagliflozin in these patients has not been previously investigated. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
CONCLUSIONS: In patients with diabetes and recent worsening of heart failure, sotagliflozin is cost-effective in the U.S. using commonly accepted willingness-to-pay thresholds. (Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure [SOLOIST-WHF]; NCT03521934). Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
METHODS: Based on SOLOIST-WHF trial data (N = 1,222), we constructed a Markov model to estimate the lifetime impact of sotagliflozin from a U.S. health care sector perspective. Cost data were sourced from the National Inpatient Sample. Life expectancy was modeled from census data and modified by the mortality rate in SOLOIST-WHF. Fatal and nonfatal event rates were carried forward from the trial data. Utility was assessed from the published reports. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
OBJECTIVES: The authors sought to determine the cost-effectiveness of sotagliflozin in patients with diabetes and recent worsening of heart failure. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
RESULTS: Lifetime quality-adjusted life-years (QALYs) were 4.43 and 4.04 in the sotagliflozin and placebo groups, respectively, and lifetime costs were |
| Source |
20,113 and |
| -- |
88,198 in the sotagliflozin and placebo groups, respectively. The point estimate incremental cost-effectiveness ratio was |
| Field link and sequence number |
1,823 per QALY gained. The probability of being cost-effective was 3.6%, 67.5%, and 89.4% at willingness-to-pay thresholds of |
| -- |
0,000, |
| -- |
00,000, and |
| -- |
50,000, respectively, per QALY gained. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Indexing |
Automated |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Health Research Institute |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Dolman, Sarahfaye |
| Institution Code |
MHRI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Kolm, Paul |
| Institution Code |
MHRI |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Weintraub, William S |
| Institution Code |
MHRI |
| 790 ## - Authors |
|---|
| All authors |
Weintraub WS, Kolm P, Dolman S, Alva M, Bhatt DL, Zhang Z |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.1016/j.jchf.2024.04.018">https://dx.doi.org/10.1016/j.jchf.2024.04.018</a> |
| Public note |
https://dx.doi.org/10.1016/j.jchf.2024.04.018 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
